Evolution of symptoms after ustekinumab induction therapy in patients with Crohn’s disease

By sjmartinez • July 2, 2023

Colombel JF, Sands BE, Gasink C, Yeager B, Adedokun OJ, Izanec J, Ma T, Gao LL, Lee SD, Targan SR, Ghosh S, Hanauer SB, Sandborn WJ. Evolution of symptoms after ustekinumab induction therapy in patients with Crohn's disease. Clin Gastroenterol Hepatol. 2023 Jun 28:S1542-3565(23)00499-8. doi: 10.1016/j.cgh.2023.06.014. Epub ahead of print. PMID: 37391056.

Tags: Cedars Sinai DoM, Crohn’s disease, Digestive Diseases, efficacy dynamics, Publications, remission, response, ustekinumab

Psychosocial and clinical characteristics in Takotsubo syndrome

Obrutu O, Cui Y, Maughan J, Marano P, Wei J, Gulati M, Lauzon M, Herscovici R, Shufelt C, Rojas N, Tjoe B, Rutledge T, Bairey[...]

Loss of TRIM21 drives UVB-induced systemic inflammation by regulating DNA-sensing pathways

Tumurkhuu G, Perri G, Moore R, Huo L, Kumar AN, Ainsworth R, Oliver T, de Los Santos G, Gibb D, Carriere J, Yu JM, Abuav[...]

Reply to the letter to the editor on “Re: “Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United States”

Danpanichkul P, Diaz LA, Arab JP, Singal AG, Yang JD. Reply to the letter to the editor on "Re: "Sex Disparities in Alcohol-Associated Liver Disease[...]